✨
AI Summary & Key Takeaways
AI Insight⚡ TL;DR(Too Long; Didn't Read)
We present a case who cleared HBsAg and achieved anti HBs positivity after treatment with convensional interferon.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Each year HBsAg clearance appears spontenously between the range of 1-2 percent of hepatit B and, also antiHBs appears in 1/3 rate of these cases.
📊
Key Findings & Data:HBsAg serokonversion is seen in 4 percent of patients treated with convensional interferon and this rate is also similar for the treatment with peginterferon.
💡
Conclusion & Impact:We present a case who cleared HBsAg and achieved anti HBs positivity after treatment with convensional interferon.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Each year HBsAg clearance appears spontenously between the range of 1-2 percent of hepatit B and, also antiHBs appears in 1/3 rate of these cases. HBsAg serokonversion is seen in 4 percent of patients treated with convensional interferon and this rate is also similar for the treatment with peginterferon. We present a case who cleared HBsAg and achieved anti HBs positivity after treatment with convensional interferon.
🔖
Cite This Article
ENÇ, F. Y., YEŞİLOĞLU, C. (2022). HBsAg seroconversion with convensional interferon treatment for chronic hepatit B. Göztepe Tıp Dergisi, Cilt: 22 - Sayı: 3, 107–108. https://ajindex.com/articles/526285